Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  KKR & Co. L.P.    KKR

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

KKR Confirms $3.74 Billion Deal to Buy Gardner Denver

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2013 | 02:26am CEST

Gardner Denver Inc. (>> Gardner Denver, Inc.) and Kohlberg Kravis Roberts & Co. confirmed the industrial-pumps manufacturer has agreed to be acquired for roughly $3.74 billion.

The New York private-equity firm will pay $76 for each Gardner Denver share, a 2.9% premium to Thursday's close. Shares were recently trading 1.4% higher at $74.91 premarket. The stock has climbed 7.8% since the start of the year.

The deal values Gardner Denver at about $3.9 billion, including the assumption of debt.

KKR had bid $75 a share for the Wayne, Pa.-based company in February and increased the offer after Gardner Denver sought a higher price.

For KKR, the deal would mark the buyout firm's third purchase in the industrials space in the past few years. KKR agreed in April 2011 to acquire Capsugel, a unit of pharmaceutical giant Pfizer Inc. (>> Pfizer Inc.) that makes drugs in capsule form. Later that year, KKR agreed to acquire Capital Safety Inc., a large provider of safety products and equipment for construction and other workers.

KKR ended up being the only serious suitor for Gardner Denver in an up-and-down sales process that dragged on in recent months.

Gardner Denver, which employs about 6,400 people and posted sales of about $2.4 billion last year, pursued a deal with rival SPX Corp. (>> SPX Corporation) late last year after garnering interest from a number of private-equity firms. SPX offered $4 billion for the company but later dropped the bid amid negative reactions from shareholders.

Write to Melodie Warner at melodie.warner@dowjones.com

Order free Annual Report for Gardner Denver Inc.

Visit http://djnewswires.ar.wilink.com/?link=GDI or call 1-888-301-0513

Stocks mentioned in the article : Gardner Denver, Inc., SPX Corporation, Pfizer Inc.
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on KKR & CO. L.P.
08/17 KKR REAL ESTATE FINANCE TRUST INC. : Reports Second Quarter 2017 Results
08/14 KKR L P : The Rebirth of Japan Inc. USA Today
08/14 China's Fosun, Shanghai Pharma say bid for stake in U.S. drugmaker Arbor
08/11 Banks picked for float of French fashion company behind Sandro, Maje - source..
08/11 KKR : Strengthens China Capabilities with Shanghai Office Opening
08/09 KKR L P : Announcement Regarding Progress Toward Conducting the Tender Offerfor ..
08/08 ENVISION HEALTHCARE : to sell ambulance business to KKR in $2.4 billion deal
08/08 KKR : To Acquire Covenant Surgical Partners
08/03 KKR REAL ESTATE FINANCE TRUST INC. : to Announce Second Quarter 2017 Results
08/03 KKR L P : Releases 2016 ESG and Citizenship Update
More news
News from SeekingAlpha
08/20 Tracking Jeffrey Ubben's ValueAct Portfolio - Q2 2017 Update
08/10 BLOOMBERG : NRG Energy renewable asset sale attracts several suitors
08/08 Envision to sell ambulance business to KKR for $2.4B
08/02 KKR declares $0.17 dividend
08/02 KKR-controlled company to acquire PharMerica for $1.4B
Financials ($)
Sales 2017 1 383 M
EBIT 2017 2 091 M
Net income 2017 1 443 M
Debt 2017 -
Yield 2017 3,75%
P/E ratio 2017 10,55
P/E ratio 2018 7,96
Capi. / Sales 2017 10,7x
Capi. / Sales 2018 10,6x
Capitalization 14 811 M
Chart KKR & CO. L.P.
Duration : Period :
KKR & Co. L.P. Technical Analysis Chart | KKR | US48248M1027 | 4-Traders
Technical analysis trends KKR & CO. L.P.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 23,3 $
Spread / Average Target 28%
EPS Revisions
Managers
NameTitle
Henry R. Kravis Co-Chairman & Co-Chief Executive Officer
George Rosenberg Roberts Co-Chairman & Co-Chief Executive Officer
Joseph Yong Bum Bae Co-President, Co-COO & Director
Scott Charles Nuttall Co-President, Co-COO & Director
William Joseph Janetschek Chief Financial Officer
Sector and Competitors
1st jan.Capitalization (M$)
KKR & CO. L.P.17.87%14 811
BLACKSTONE GROUP LP16.61%37 767
LEGAL & GENERAL7.75%20 460
T. ROWE PRICE GROUP INC9.35%19 781
AMUNDI37.58%15 747
HARGREAVES LANSDOWN10.47%8 182